Jonsson Comprehensive Cancer Center: clinical-trial pipeline

Jonsson Comprehensive Cancer Center is the sponsor of 392 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 114 are not yet finished and 0 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials114
Phase 2/3 and 319
Countries7
New in 90 days0

Trials by phase

PhaseTrials
Phase 2122
Not applicable117
Phase 183
Phase 1/230
Early phase 119
Phase 319
Phase 42

Trials by status

StatusTrials
Completed171
Recruiting56
Active, not recruiting47
Terminated41
Withdrawn or not authorised38
Unknown28
Not yet recruiting11

Condition areas

AreaTrials
Oncology379
Nephrology and urology89
Gastroenterology and liver29
Women's health and obstetrics18
Dermatology15
Infectious disease and vaccines12
Metabolic and endocrine (diabetes, obesity)10
Haematology7
Psychiatry and mental health5
Rare and genetic diseases5
Ophthalmology4
Musculoskeletal3

Countries

CountryTrials
United States368
Canada4
United Kingdom3
Australia2
Germany1
France1
Sweden1

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT04453072A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adult…Not applicableRecruitingUnited States
NCT07716735Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutan…Phase 1Not yet recruitingUnited States
NCT06448286PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patient…Phase 3Not yet recruitingUnited States
NCT06543576External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of St…Phase 1/2RecruitingUnited States
NCT06436612Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdo…Phase 2RecruitingUnited States
NCT06788938Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine NeoplasmsPhase 2Active, not recruitingUnited States
NCT06934239A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast C…Phase 4RecruitingUnited States
NCT03601455Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Loc…Phase 2Active, not recruitingUnited States
NCT05398302Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant P…Phase 1RecruitingUnited States
NCT02280161Germ-Line Mutations in Blood and Saliva Samples From Patients With CancerNot applicableRecruitingUnited States
NCT07242365Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing…Phase 2Active, not recruitingUnited States
NCT04147494Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal…Early phase 1Active, not recruitingUnited States
NCT06288113Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuP…Phase 2RecruitingUnited States
NCT07468916Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syn…Phase 2Not yet recruitingUnited States
NCT07468903Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate CancerNot applicableRecruitingUnited States
NCT04297020Brain Health in Breast Cancer SurvivorsNot applicableRecruitingUnited States
NCT06090903Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Gliobla…Not applicableRecruitingUnited States
NCT06650163Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectab…Phase 1RecruitingUnited States
NCT04945642High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaNot applicableRecruitingUnited States
NCT07461948Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma PatientsPhase 3RecruitingUnited States
NCT07310004Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast BiopsiesNot applicableRecruitingUnited States
NCT07634601Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Can…Phase 2Not yet recruitingUnited States
NCT06216249Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castra…Phase 2RecruitingUnited States
NCT06059690Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Mea…Phase 1/2RecruitingUnited States
NCT02296229Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate CancerNot applicableActive, not recruitingUnited States

All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

APIMCP tool clinical_trialsData licence

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "Jonsson Comprehensive Cancer Center clinical trials: 114 open, 19 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/jonsson-comprehensive-cancer-center/, data as of 2026-10-25.